Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →21
🟡 Moderate
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
12,515
Total Claims
$1.2M
Drug Cost
882
Beneficiaries
$1,305
Cost/Patient
Risk Score Breakdown 21/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
+29%
Opioid rate vs peers
2.9% vs 2.2% avg
-7%
Cost per patient vs peers
$1,305 vs $1,411 avg
+6%
Brand preference vs peers
11.3% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
2.9%
Opioid Rate
362
Opioid Claims
$6,841
Opioid Cost
6.4%
Long-Acting Rate
Brand vs Generic
Brand: 1,402 claims · $931K
Generic: 11,031 claims · $216K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 152 | $176K |
| Dulaglutide | 118 | $156K |
| Empagliflozin | 120 | $149K |
| Apixaban | 92 | $97K |
| Dapagliflozin Propanediol | 23 | $41K |
| Rivaroxaban | 16 | $25K |
| Fluticasone/Vilanterol | 40 | $24K |
| Fluticasone/Umeclidin/Vilanter | 28 | $24K |
| Rsv Vacc, Pref A And Pref B/Pf | 57 | $19K |
| Insulin Glargine,hum.Rec.Anlog | 24 | $16K |
| Insulin Glargine,hum.Rec.Anlog | 20 | $15K |
| Insulin Aspart | 17 | $12K |
| Insulin Glargine,hum.Rec.Anlog | 24 | $12K |
| Levothyroxine Sodium | 709 | $9,134 |
| Atorvastatin Calcium | 782 | $9,054 |
Prescribing Profile
Patient Profile
75
Avg Age
76%
Female
1.08
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About